Synergistic action of alkylating agents and methylxanthine derivatives in the treatment of chronic lymphocytic leukemia

Leukemia. 1995 Dec;9(12):2159-61.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Chlorambucil / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Drug Synergism
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Pentoxifylline / administration & dosage
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Theophylline / administration & dosage
  • Xanthines / administration & dosage

Substances

  • Antineoplastic Agents, Alkylating
  • Phosphodiesterase Inhibitors
  • Xanthines
  • Chlorambucil
  • methylxanthine
  • Cyclophosphamide
  • Theophylline
  • Pentoxifylline